Frazier Life Sciences Management L.P. lifted its holdings in Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) by 4.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,131,008 shares of the biotechnology company’s stock after buying an additional 145,251 shares during the quarter. Alpine […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) has been assigned an average recommendation of “Buy” from the seven brokerages that are presently covering the company, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy rating. The average 1 year target price among brokerages that have updated their coverage […]
Alpine Immune Sciences' (ALPN) Outperform Rating Reaffirmed at Wedbush themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Alpine Immune Sciences (NASDAQ:ALPN) Reaches New 52-Week High at $32.33 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Alpine Immune Sciences (NASDAQ:ALPN) Shares Up 8.9% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.